PCJ Analyst Ratings
Strong Buy
4 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
PCJ Stock 12 Month Forecast
Average Price Target
―| Highest Price TargetCHF24.66 | Average Price TargetCHF18.09 | Lowest Price TargetCHF13.98 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Roth MKM
CHF13.98
Buy
―
Initiated
09/19/26
Cantor Fitzgerald
CHF23.02→CHF24.66
Buy
―
Assigned
09/17/26
H.C. Wainwright
CHF16.44
Buy
―
Reiterated
08/24/26
Alliance Global Partners
CHF16.44
Buy
―
Reiterated
05/13/26
Stifel Nicolaus
CHF13.98
Buy
―
Reiterated
03/18/26
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Roth MKM
CHF13.98
Buy
―
Initiated
09/19/26
Cantor Fitzgerald
CHF23.02→CHF24.66
Buy
―
Assigned
09/17/26
H.C. Wainwright
CHF16.44
Buy
―
Reiterated
08/24/26
Alliance Global Partners
CHF16.44
Buy
―
Reiterated
05/13/26
Stifel Nicolaus
CHF13.98
Buy
―
Reiterated
03/18/26
Best Analysts Covering Abeona Therapeutics
3 Months
Success Rate
5/7 ratings generated profit
Average Return
+2.86%
Copying James Molloy's trades and holding each position for 3 Months would result in 71.43% of your transactions generating a profit, with an average return of +2.86% per trade.
1 Year
Success Rate
8/13 ratings generated profit
Average Return
+1.07%
Copying Ram Selvaraju's trades and holding each position for 1 Year would result in 61.54% of your transactions generating a profit, with an average return of +1.07% per trade.
2 Years
Success Rate
5/7 ratings generated profit
Average Return
+19.56%
Copying James Molloy's trades and holding each position for 2 Years would result in 71.43% of your transactions generating a profit, with an average return of +19.56% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
PCJ Analyst Recommendation Trends
Rating
May 26
Jun 26
Jul 26
Aug 26
Sep 26
Strong Buy
10
5
5
3
5
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
10
5
5
3
5
Each month's total comprises the sum of three months' worth of ratings.
PCJ Financial Forecast
PCJ Stock Forecast FAQ
What is CH:PCJ’s average 12-month price target, according to analysts?
Based on analyst ratings, Abeona Therapeutics’s 12-month average price target is 18.09.
What is CH:PCJ’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for CH:PCJ, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Abeona Therapeutics a Buy, Sell or Hold?
Abeona Therapeutics has a consensus rating of Strong Buy, which is based on 4 buy ratings, 0 hold ratings and 0 sell ratings.
What is Abeona Therapeutics’s share price target?
The average share price target for Abeona Therapeutics is 18.09. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is CHF24.66 ,and the lowest forecast is CHF13.98. The average share price target represents N/A Increase from the current price of N/A.
The highest analyst share price target is CHF24.66 ,and the lowest forecast is CHF13.98. The average share price target represents N/A Increase from the current price of N/A.
What do analysts say about Abeona Therapeutics?
Abeona Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
How can I buy shares of Abeona Therapeutics?
To buy shares of CH:PCJ, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.